[Effectiveness of imatinib mesylate in treatment for dermatofibroma protuberans].

Moiseenko, V M; Chudenko, V A; Orlova, R V; Imianitov, E N; Matsko, D E; Gafton, G I; Kochnev, V A; Protsenko, S A; Mikhailichenko, T D; Nogaeva, T Kh

Moiseenko, V M; Chudenko, V A; Orlova, R V; Imianitov, E N; Matsko, D E; Gafton, G I; Kochnev, V A; Protsenko, S A; Mikhailichenko, T D; Nogaeva, T Kh.

Vopr Onkol ; 54(5): 656-60, 2008.

Article in Ru | MEDLINE | ID: mdl-19069485

Subject(s)

Antineoplastic Agents/therapeutic use; Dermatofibrosarcoma/drug therapy; Dermatofibrosarcoma/pathology; Piperazines/therapeutic use; Pyrimidines/therapeutic use; Benzamides; Dermatofibrosarcoma/enzymology; Humans; Imatinib Mesylate; Male; Protein Kinase Inhibitors/therapeutic use; Protein-Tyrosine Kinases/antagonists & inhibitors; Treatment Outcome; Young Adult

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Piperazines / Pyrimidines / Dermatofibrosarcoma / Antineoplastic Agents Limits: Adult / Humans / Male Language: Ru Journal: Vopr Onkol Year: 2008 Document type: Article Country of publication: RUSSIA

Search on Google

Add to My VHL

XML

PubMed Links